GGrantIndex
← Leaderboards

Xinglong Wang

Case Western Reserve University

$12,617,230
Attributed
$14,821,218
Total exposure
11
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.4M · FY201325
$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,821,218 · 11

By mechanism

R01$7,210,080 · 6
RF1$7,019,328 · 3
R21$433,497 · 1
R03$158,313 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Neurons

Research focus

NeuronsInsightAlzheimer&AposMediatingIn VivoInvestigationMolecularMitochondrial DysfunctionNew Therapeutic TargetMitochondriaNerve DegenerationTransgenic MiceNeurodegenerative DisordersPlayCellsBasePilot ProjectsProteinsTherapeutic InterventionOrganellesIn VitroDisease ProgressionImpairmentPathogenesis

Grant awards (27)

FAM222A and amyloid plaque deposition in Alzheimer's Disease$680,334
R01 · FY2025 · AG · contact PI
TDP-43 LLPS and mitochondrial dysfunction in neurodegeneration$638,682
R01 · FY2025 · AG · contact PI
Mitochondrial modulation of neuroinflammation in AD and related tauopathies$539,986
R01 · FY2025 · AG · contact PI
Tailor-Made Molecular Chaperones to Target Protein Misfolding$513,463
R01 · FY2025 · AG
Tailor-Made Molecular Chaperones to Target Protein Misfolding$523,941
R01 · FY2024 · AG
Tailor-Made Molecular Chaperones to Target Protein Misfolding$541,441
R01 · FY2023 · AG
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALS$396,330
R01 · FY2021 · NS · contact PI
FAM222A and amyloid plaque deposition in Alzheimer's Disease$1,815,200
RF1 · FY2020 · AG · contact PI
Mitochondrial modulation of neuroinflammation in AD and related tauopathies$1,568,250
RF1 · FY2020 · AG · contact PI
FAM222A and amyloid plaque deposition in Alzheimer's Disease$1,013,931
RF1 · FY2020 · AG · contact PI
Mitochondrial modulation of neuroinflammation in AD and related tauopathies$612,364
RF1 · FY2020 · AG · contact PI
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALS$410,577
R01 · FY2020 · NS · contact PI
Mitochondrial TDP-43 in Alzheimer's Disease$1,154,653
RF1 · FY2019 · AG · contact PI
Mitochondrial TDP-43 in Alzheimer's Disease$548,931
RF1 · FY2019 · AG · contact PI
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALS$410,577
R01 · FY2019 · NS · contact PI
Mitochondrial TDP-43 in Alzheimer's Disease$305,999
RF1 · FY2019 · AG · contact PI
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALS$410,577
R01 · FY2018 · NS · contact PI
TDP-43 and Mitochondrial Dysfunction in ALS$346,719
R01 · FY2018 · NS · contact PI
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALS$410,577
R01 · FY2017 · NS · contact PI
TDP-43 and Mitochondrial Dysfunction in ALS$346,719
R01 · FY2017 · NS · contact PI
TDP-43 and Mitochondrial Dysfunction in ALS$346,719
R01 · FY2016 · NS · contact PI
TDP-43 and Mitochondrial Dysfunction in ALS$346,719
R01 · FY2015 · NS · contact PI
TDP-43 and Mitochondrial Dysfunction in ALS$346,719
R01 · FY2014 · NS · contact PI
Elucidating the Pathogenic Mechanisms of VPS35 Mutations in Parkinson's Disease$235,372
R21 · FY2014 · NS · contact PI
Role of PS1 in Mitochondria Dynamics and Mitochondria Function$79,250
R03 · FY2014 · AG · contact PI
Elucidating the Pathogenic Mechanisms of VPS35 Mutations in Parkinson's Disease$198,125
R21 · FY2013 · NS · contact PI
Role of PS1 in Mitochondria Dynamics and Mitochondria Function$79,063
R03 · FY2013 · AG · contact PI